Segall Bryant & Hamill’s Inogen INGN Stock Holding History

Segall Bryant & Hamill’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-17,323	Closed	-$894K	–	794
2020 Q1	$894K	Sell	17,323 -1,301	-7%	-$62.5K	0.02%	471
2019 Q4	$1.27M	Sell	18,624 -1,413	-7%	-$88.6K	0.02%	475
2019 Q3	$960K	Sell	20,037 -9,716	-33%	-$507K	0.01%	528
2019 Q2	$1.99M	Buy	29,753 +6,884	+30%	+$524K	0.03%	408
2019 Q1	$2.18M	Buy	22,869 +13,972	+157%	+$1.74M	0.03%	396
2018 Q4	$1.1M	Buy	8,897 +1,491	+20%	+$246K	0.02%	503
2018 Q3	$1.81M	Buy	7,406 +1,171	+19%	+$271K	0.03%	451
2018 Q2	$1.16M	Buy	+6,235	New	+$1.04M	0.02%	515

Other funds holding INGN

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Segall Bryant & Hamill's INGN Position: Q2 2020 in Review

Segall Bryant & Hamill sold out of Inogen (INGN) in Q2 2020, closing a stake of 17,323 shares — an estimated $894K sold.

Segall Bryant & Hamill first reported a position in INGN in Q2 2018 and held it in 8 quarters. The position peaked at $2.18M in Q1 2019. 165 funds tracked by Wall St. Rank hold INGN as of Q2 2020.

Segall Bryant & Hamill reported no remaining Inogen position as of Q2 2020 after selling out during the quarter.
Segall Bryant & Hamill sold 17,323 Inogen shares in Q2 2020, an estimated $894K.
Segall Bryant & Hamill first reported a position in Inogen in Q2 2018 and held it in 8 quarters.
Segall Bryant & Hamill's Inogen position peaked at $2.18M in Q1 2019.
165 funds tracked by Wall St. Rank held Inogen as of Q2 2020.

Based on Segall Bryant & Hamill's 13F filing for Q2 2020, filed 14 Aug 2020.